Evidence map›Paper›PMID 42721080›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Actuation of CRP activating region 3 by formylation modulates the

Renato E R S Santos, Pallabi Basu, Brendan J O'Hara, Jacob A Gibson, Michael J Gebhardt, Chris Akut, William P Robins, John J Mekalanos, Simon L Dove, Paula I Watnick

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Renato E R S Santos *Division of Infectious Diseases, Boston Children's Hospital, Boston, MA 02115.ORCID 0000-0002-8702-4202
Pallabi Basu *Division of Infectious Diseases, Boston Children's Hospital, Boston, MA 02115.ORCID 0000-0002-8163-7518
Brendan J O'HaraDivision of Infectious Diseases, Boston Children's Hospital, Boston, MA 02115.
Jacob A GibsonDivision of Infectious Diseases, Boston Children's Hospital, Boston, MA 02115.ORCID 0000-0002-7493-3722
Michael J GebhardtDepartment of Microbiology and Immunobiology, University of Iowa, Iowa City, IA 52242.ORCID 0000-0002-1213-8408
Chris AkutDivision of Infectious Diseases, Boston Children's Hospital, Boston, MA 02115.ORCID 0009-0004-0461-1287
William P RobinsDepartment of Microbiology, Harvard Medical School, Boston, MA 02115.
John J MekalanosDepartment of Microbiology, Harvard Medical School, Boston, MA 02115.
Simon L DoveDivision of Infectious Diseases, Boston Children's Hospital, Boston, MA 02115.ORCID 0000-0002-3758-608X
Paula I WatnickDivision of Infectious Diseases, Boston Children's Hospital, Boston, MA 02115.ORCID 0000-0002-9173-8662

Funding

Genetic Analysis of Toxinogenesis in Vibrio CholeraeR01AI018045 · NIAID · HARVARD MEDICAL SCHOOL · PI MEKALANOS, JOHN JOSEPH · 2009 to 2018
$6.7M
Global regulators converge to orchestrate metabolism, biofilm, and pathogenesisR01AI112652 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI WATNICK, PAULA I · 2014 to 2025
$4.8M
Control of intestinal innate immunity by the commensal microbiota in a model hostR01AI158247 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI WATNICK, PAULA I · 2021 to 2025
$3.5M
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) F32AI86459HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI018045HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01 AI112652NIAID NIH HHS R01 AI018045NIAID NIH HHS R01 AI112652NIAID NIH HHS R01 AI158247
6 · The paper itself

Abstract

The cyclic AMP receptor protein or CRP is a global regulator of bacterial metabolism. CRP activates transcription of genes required for utilization of alternative carbon sources in response to the second messenger cAMP, which is synthesized in the setting of glucose scarcity. Transcription is activated through contact with RNA polymerase at three sites termed activating regions (ARs) 1-3. AR3 was previously reported to be functional only when CRP K52 was mutated to a neutral residue and to be essential for transcription only in the absence of AR1 and AR2. To probe the role of AR3 at the genome level, we used chromatin immunoprecipitation sequencing and RNA sequencing to compare WT CRP with a CRP K52Q mutant. This mutation resulted in hundreds of novel CRP chromosomal binding sites and differentially regulated transcripts including the small RNA CrbZ which represses acetate utilization. CrbZ was expressed by wild-type

Indexed as

Bacterial ProteinsCyclic AMP Receptor ProteinDNA DamageOxidative StressVibrio choleraeBinding SitesGene Expression Regulation, BacterialMutationTranscription, GeneticBacterial ProteinsCyclic AMP Receptor Proteinacetylationposttranslational modificationtranscriptiontranscription regulationVibrio cholerae

Identifiers

PMID42721080
PMCPMC13564382

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.